Yifeng
Yifeng Pharmacy Chain Co., Ltd. engages in pharmaceutical retail business in China.
Yifeng, founded in June, 2008 and headquartered in Changde, is a national large-scale pharmaceutical retail chain enterprise. The founder is Gao Yi. Listed on the SSE on February 17, 2015, the company's major shareholders are Ningbo Meishan Bonded Port Zone Jikang Enterprise Management Partnership (LP), Hong Kong Central Clearing Co., Ltd. and Gao Yi. Rivals that have direct and indirect competition with Yifeng include 111 Group, JD health, Glaxo Smith Kline, Pfizer, etc.
Chinese Jewelry's Enterprises Journey to Go Global
26-year-old Xiaolin plans to marry his girlfriend of five years, and purchasing gold and silver jewelry is an essential part of the wedding preparations. When he went shopping, he was shocked to find that the prices of gold and silver jewelry had skyrocketed. A ring he liked last year had already increased in price by 17% this year.
Aug 20, 2024 05:17 PM
Research
Consumer Staples, Healthcare, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Consumer Discretionary, Consumer Staples, TechnologyTech for Global, Globalization Footprints of the Established and the New
Pharmaceutical business concept stocks quickly rose the first pharmaceutical trading limit
Lack of Trust in AI Tech Leads Singaporean Companies to Cut Investments
Dec 19, 2024 04:50 PM
Zhongyuan Home revises overseas strategy, focuses on new retail business.
Dec 09, 2024 02:35 PM
Rice ball takeout has officially entered the Australian market, and high-quality takeout services have captured overseas food
Robosen completed round B and round B + financing of nearly US $100 million
The new brand Hutou Bureau has signed a strategic cooperation with tmall. In the future, heavy new products will be launched in tmall
Happy cake has completed a new round of financing of RMB 100 million, led by Asian business capital and followed by Chunjian capital. The listing plan will be launched in the future
Weixiaofan, a new digital fast food brand, has completed a round of financing of nearly 100 million yuan, with Tiantu's exclusive investment
Yuntianhua: the shareholder completed the reduction of 2% of the shares with the investment of Yuntianhua
Yifeng: Xiao Zaixiang, the Vice President, Intends to Sell Shares